Home/Filings/4/0000882796-05-000030
4//SEC Filing

BIOCRYST PHARMACEUTICALS INC 4

Accession 0000882796-05-000030

$BCRXCIK 0000882796operating

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 12:35 PM ET

Size

5.6 KB

Accession

0000882796-05-000030

Insider Transaction Report

Form 4
Period: 2005-05-31
Nugent Jonathan M
VP Corp Communications
Transactions
  • Award

    Stock Option

    2005-05-31$4.66/sh+35,000$163,10035,000 total
    Exercise: $4.66From: 2006-05-31Exp: 2015-05-31Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]Four year vesting schedulde. 25% after 12 months from original grant date. 1/48 each following month.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000882796

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 12:35 PM ET
Size
5.6 KB